<narrative>QMJ C - Oceania - Multicountry Western Pacific (01-Jul-2015-31-Dec-2017)</narrative>

47045-QUA-C-UNDP-1

The Global Fund to Fight AIDS, Tuberculosis and Malaria

<narrative>QMJ C - Oceania - Multicountry Western Pacific (01-Jul-2015-31-Dec-2017)</narrative> Multicountry Western Pacific, TB/HIV, United Nations Development Programme Goals: To halt the spread of HIV among the population of the Western Pacific and maintain HIV incidence rates below 0.1 percent annually in the 2015-2017 period; To promote universal and equitable access to quality diagnosis and appropriate treatment of TB, MDR-TB, TB/DM and TB/HIV patients across 11 Pacific Island Countries; To reduce AIDS-related mortality by strengthening HIV case finding and case management; To reduce the prevalence, incidence and mortality from all forms of TB in the 11 Pacific Island Countries, thereby contributing to the post-2015 global TB strategy. Objectives: Objective 1: Increase coverage of HIV-prevention services, with a special focus on key populations and other vulnerable populations; Objective 2: Strengthen coverage and quality of treatment, care and support for PLHIV, with special attention for adherence; Objective 3: Improve and expand use of strategic information to inform policy, programming, research and address structural barriers; Objective 4: To provide early rapid and quality diagnosis of TB, MDR-TB, TB/DM and TB/HIV with specific focus on screening and diagnosis in selected and prioritized hard to reach, vulnerable groups across 11 PICs; Objective 5: To sustain high quality treatment for all forms of TB including drug‐resistant TB and HIV related TB with patient support; Objective 6: To prevent TB through diagnosis and treatment of latent TB infection for high risk groups and scaling up of infection control measures.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division

Sandra Irbe

Fund Portfolio Manager

+41 58 791 1700 sandra.irbe@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

Multicountry Western Pacific

TB/HIV TB/HIV Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases

5821710.00 Global Fund commitment to QUA-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

3086356.00 Global Fund disbursement to QUA-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund disbursement to QUA-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1838306.00 Global Fund disbursement to QUA-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-872048.00 Global Fund commitment to QUA-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

6639510.00 Global Fund commitment to QUA-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

3361005.00 Global Fund disbursement to QUA-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1108843.00 Global Fund disbursement to QUA-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1141703.00 Global Fund disbursement to QUA-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1328641.54 Global Fund commitment to QUA-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-1027959.00 Global Fund commitment to QUA-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

274171.00 Global Fund disbursement to QUA-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1054470.54 Global Fund disbursement to QUA-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund commitment to QUA-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund disbursement to QUA-C-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

<narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime.

<narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants.

<narrative>MDR-TB-other 1: Proportion of detected rifampicin-resistan TBt cases (RR-TB) and MDR-TB cases and that start treatment within four weeks from diagnosis</narrative> Module: MDR-TB. <narrative>MDR-TB-other 1: Proportion of detected rifampicin-resistan TBt cases (RR-TB) and MDR-TB cases and that start treatment within four weeks from diagnosis</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 1; Denominator: 1.

Numerator: 2; Denominator: 2.

Numerator: 1; Denominator: 3.

<narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative> Module: MDR-TB. <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 0; Denominator: 58.

Numerator: 3; Denominator: 15.

Numerator: 19; Denominator: 19.

<narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative> Module: PMTCT. <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 1; Denominator: 15; Percentage: 6.7%.

Numerator: 4; Denominator: 8; Percentage: 50%. Numerator: 0.

Numerator: 6; Denominator: 9; Percentage: 66.7%.

Numerator: 7; Denominator: 10; Percentage: 70%. Numerator: 1; Denominator: 1; Percentage: 100%.

<narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative> Module: PMTCT. <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 1; Denominator: 15; Percentage: 6.7%.

Numerator: 4; Denominator: 8; Percentage: 50%. Numerator: 2.

Numerator: 6; Denominator: 9; Percentage: 66.7%.

Numerator: 7; Denominator: 10; Percentage: 70%. Numerator: 1; Denominator: 1; Percentage: 100%.

<narrative>Percentage of pregnant women who know their HIV status</narrative> Module: PMTCT. <narrative>Percentage of pregnant women who know their HIV status</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 1211; Denominator: 24700.

Numerator: 7537; Denominator: 12561. Numerator: 7484; Denominator: 8280.

Numerator: 8900; Denominator: 12714.

Numerator: 10296; Denominator: 12871. Numerator: 15592; Denominator: 21227.

<narrative>Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative> Module: Prevention programs for MSM and TGs. <narrative>Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 0; Denominator: 7460.

Numerator: 772; Denominator: 7722.

Numerator: 1172; Denominator: 7814. Numerator: 281; Denominator: 7814.

<narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Module: Prevention programs for MSM and TGs. <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 0; Denominator: 7460.

Numerator: 529; Denominator: 7722.

Numerator: 710; Denominator: 7814. Numerator: 167; Denominator: 7814.

<narrative>Percentage of antenatal care attendees tested for syphilis</narrative> Module: Prevention programs for general population. <narrative>Percentage of antenatal care attendees tested for syphilis</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 23995; Denominator: 27998.

Numerator: 24475; Denominator: 28138. Numerator: 7834; Denominator: 8280.

Numerator: 25464; Denominator: 28420.

Numerator: 26492; Denominator: 28705. Numerator: 15944; Denominator: 21227.

<narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative> Module: RSSH: Health management information systems and M&E. <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 7; Denominator: 11.

Numerator: 7; Denominator: 11. Numerator: 8; Denominator: 11.

Numerator: 9; Denominator: 11.

Numerator: 11; Denominator: 11. Numerator: 9; Denominator: 11.

Numerator: 475. Numerator: 514.

Numerator: 502.

Numerator: 531. Numerator: 920; Percentage: 120%.

<narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative> Module: TB care and prevention. <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 336.

Numerator: 181. Numerator: 247.

Numerator: 196.

Numerator: 218. Numerator: 417; Percentage: 120%.

<narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative> Module: TB care and prevention. <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 286; Denominator: 336.

Numerator: 154; Denominator: 181. Numerator: 304; Denominator: 356.

Numerator: 169; Denominator: 196.

Numerator: 189; Denominator: 218. Numerator: 361; Denominator: 403.

<narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Module: TB care and prevention. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 7; Denominator: 9.

Numerator: 7; Denominator: 9. Numerator: 0; Denominator: 0.

Numerator: 8; Denominator: 9.

Numerator: 8; Denominator: 9. Numerator: 11; Denominator: 9.

Numerator: 404; Denominator: 475. Numerator: 720; Denominator: 864.

Numerator: 432; Denominator: 502.

Numerator: 462; Denominator: 531. Numerator: 874; Denominator: 1007.

<narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative> Module: TB/HIV. <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 530; Denominator: 936.

Numerator: 266; Denominator: 514.

Numerator: 566; Denominator: 918.

<narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative> Module: Treatment, care and support. <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative> Geographic coverage: National. Aggregation: Non cumulative - other. Numerator: 34; Denominator: 85; Percentage: 40%.

Numerator: 42; Denominator: 98; Percentage: 42.9%. Numerator: 39.

Numerator: 57; Denominator: 105; Percentage: 54.3%.

Numerator: 72; Denominator: 112; Percentage: 64.3%. Numerator: 39; Denominator: 74; Percentage: 52.7%.

47045-QUA-C-UNDP-2

The Global Fund to Fight AIDS, Tuberculosis and Malaria

<narrative>Multi-country Western Pacific (MWP) Integrated HIV/TB Program - Oceania - Multicountry Western Pacific (01-Jan-2018-31-Dec-2020)</narrative> Multicountry Western Pacific, TB/HIV, United Nations Development Programme Goals: To halt the spread of HIV among the population of the Western Pacific and maintain HIV incidence rates below 0.1 percent annually; To reduce AIDS-related mortality by strengthening HIV case finding and case management; To reduce the prevalence, incidence and mortality from all forms of TB in the 11 Pacific Island Countries, thereby contributing to the post-2015 global TB strategy; To promote universal and equitable access to quality diagnosis and appropriate treatment of TB, MDR-TB, TB/DM and TB/HIV patients across 11 Pacific Island Countries. Objectives: Increase coverage of HIV-prevention services, with a special focus on key populations and other vulnerable populations; Strengthen coverage and quality of treatment, care and support for PLHIV, with special attention for adherence; To provide early rapid and quality diagnosis of TB, MDR-TB, TB/DM and TB/HIV with specific focus on screening and diagnosis in selected and prioritized hard to reach, vulnerable groups across 11 PICs; To sustain high quality treatment for all forms of TB including drug‐resistant TB and HIV related TB with patient support.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division

Sandra Irbe

Fund Portfolio Manager

+41 58 791 1700 sandra.irbe@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

Multicountry Western Pacific

Multicomponent, RSSH Tuberculosis HIV Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage

HIV -> Comprehensive prevention programs for MSM -> Addressing stigma, discrimination and violence against MSM

HIV -> Comprehensive prevention programs for MSM -> Behavioral interventions for MSM

HIV -> Comprehensive prevention programs for MSM -> Community empowerment for MSM

HIV -> Comprehensive prevention programs for MSM -> Condoms and lubricant programming for MSM

HIV -> Comprehensive prevention programs for TGs -> Addressing stigma, discrimination and violence against TGs

HIV -> Comprehensive prevention programs for TGs -> Behavioral interventions for TGs

HIV -> Comprehensive prevention programs for TGs -> Community empowerment for transgender people

HIV -> Comprehensive prevention programs for TGs -> Condoms and lubricant programming for TGs

HIV -> Comprehensive prevention programs for TGs -> HIV testing services for TGs

HIV -> Comprehensive prevention programs for TGs -> Other intervention(s) for TGs

HIV -> Comprehensive prevention programs for sex workers and their clients -> Addressing stigma, discrimination and violence against sex workers

HIV -> Comprehensive prevention programs for sex workers and their clients -> Behavioral interventions for sex workers

HIV -> Comprehensive prevention programs for sex workers and their clients -> Condoms and lubricant programming for sex workers

HIV -> Comprehensive prevention programs for sex workers and their clients -> Other intervention(s) for sex workers and their clients

HIV -> PMTCT -> Prong 1: Primary prevention of HIV infection among women of childbearing age

HIV -> PMTCT -> Prong 3: Preventing vertical HIV transmission

HIV -> Prevention programs for adolescents and youth, in and out of school -> Community mobilization and norms change

HIV -> Prevention programs for other vulnerable populations -> Behavioral interventions for other vulnerable populations

HIV -> Prevention programs for other vulnerable populations -> Diagnosis and treatment of STIs and other sexual health services for other vulnerable populations

HIV -> Prevention programs for other vulnerable populations -> HIV testing services for other vulnerable populations

HIV -> Prevention programs for other vulnerable populations -> Other intervention(s) for other vulnerable populations

HIV -> Treatment, care and support -> Counseling and psycho-social support

HIV -> Treatment, care and support -> Differentiated ART service delivery

HIV -> Treatment, care and support -> Other intervention(s) for treatment

HIV -> Treatment, care and support -> Prevention, diagnosis and treatment of opportunistic infections

HIV -> Treatment, care and support -> Treatment monitoring - Viral load

Multicomponent -> Program management -> Coordination and management of national disease control programs

Multicomponent -> Program management -> Grant management

RSSH -> RSSH: Community systems strengthening -> Community-led research and advocacy

RSSH -> RSSH: Community systems strengthening -> Institutional capacity building, planning and leadership development

RSSH -> RSSH: Community systems strengthening -> Other community responses and systems intervention(s)

RSSH -> RSSH: Community systems strengthening -> Social mobilization, building community linkages and coordination

RSSH -> RSSH: Health management information systems and M&E -> Other health information systems and M&E intervention(s)

RSSH -> RSSH: Health products management systems -> Supply chain infrastructure and development of tools

RSSH -> RSSH: Human resources for health, including community health workers -> Capacity building for health workers, including those at community level

RSSH -> RSSH: Integrated service delivery and quality improvement -> Laboratory systems for disease prevention, control, treatment and disease surveillance

RSSH -> RSSH: Integrated service delivery and quality improvement -> Other service delivery intervention(s)

RSSH -> RSSH: Integrated service delivery and quality improvement -> Service delivery infrastructure

RSSH -> RSSH: Integrated service delivery and quality improvement -> Supportive policy and programmatic environment

Tuberculosis -> MDR-TB -> Case detection and diagnosis (MDR-TB)

Tuberculosis -> MDR-TB -> Treatment (MDR-TB)

Tuberculosis -> TB care and prevention -> Case detection and diagnosis (TB care and prevention)

Tuberculosis -> TB care and prevention -> Collaborative activities with other programs and sectors (TB care and prevention)

Tuberculosis -> TB care and prevention -> Community TB care delivery

Tuberculosis -> TB care and prevention -> Engaging all care providers (TB care and prevention)

Tuberculosis -> TB care and prevention -> Other TB care and prevention intervention(s)

Tuberculosis -> TB care and prevention -> Prevention (TB care and prevention)

Tuberculosis -> TB care and prevention -> Treatment (TB care and prevention)

Tuberculosis -> TB/HIV -> Collaborative activities with other programs and sectors (TB/HIV)

Tuberculosis -> TB/HIV -> Key populations (TB/HIV) - Others

Tuberculosis -> TB/HIV -> Key populations (TB/HIV) - Prisoners

Tuberculosis -> TB/HIV -> Other TB/HIV intervention(s)

Tuberculosis -> TB/HIV -> TB/HIV - Collaborative interventions

3770425.00

3055430.17

4542857.77

6249262.97 Global Fund commitment to QUA-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1520506.88 Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

936458.73 Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund commitment to QUA-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

717073.40 Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

856429.15 Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1243709.32 Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

50000.00 Global Fund commitment to QUA-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-25000.00 Global Fund commitment to QUA-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

975085.49 Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

3120055.72 Global Fund commitment to QUA-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

240570.48 Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

746945.68 Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1192983.26 Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

939556.30 Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-50000.00 Global Fund commitment to QUA-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1650433.31 Global Fund commitment to QUA-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

75000.00 Global Fund commitment to QUA-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

50000.00 Global Fund commitment to QUA-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-75000.00 Global Fund commitment to QUA-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

208623.06 Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

699445.25 Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

742365.00 Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund disbursement to QUA-C-UNDPP02 (Other 3rd Party).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-25000.00 Global Fund commitment to QUA-C-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

3770373.00 Expenditure reported by United Nations Development Programme for QUA-C-UNDPP02, Jan 2018 to Dec 2018.

United Nations Development Programme

3055429.85 Expenditure reported by United Nations Development Programme for QUA-C-UNDPP02, Jan 2019 to Dec 2019.

United Nations Development Programme

4179803.64 Expenditure reported by United Nations Development Programme for QUA-C-UNDPP02, Jan 2020 to Dec 2020.

United Nations Development Programme

129557.00 Expenditure reported by United Nations Development Programme for QUA-C-UNDPP02, Jan 2021 to Jun 2021.

United Nations Development Programme

<narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime.

<narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants.

<narrative>Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative> Module: Comprehensive prevention programs for MSM. <narrative>Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative> Aggregation: Cumulative annually. Numerator: 54; Denominator: 9284.

Numerator: 673; Denominator: 9284. Numerator: 665; Denominator: 665.

Numerator: 1035; Denominator: 9284. Numerator: 1472; Denominator: 9284.

Numerator: 1592; Denominator: 9284. Numerator: 1549; Denominator: 9284.

<narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Module: Comprehensive prevention programs for MSM. <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Aggregation: Cumulative annually. Numerator: 23; Denominator: 9284.

Numerator: 289; Denominator: 9284. Numerator: 561; Denominator: 9284.

Numerator: 445; Denominator: 9284. Numerator: 1160; Denominator: 9284.

Numerator: 685; Denominator: 9284. Numerator: 984; Denominator: 9284.

<narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative> Module: Comprehensive prevention programs for TGs. <narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative> Aggregation: Cumulative annually. Numerator: 84; Denominator: 18569.

Numerator: 1345; Denominator: 18569. Numerator: 950; Denominator: 18569.

Numerator: 2070; Denominator: 18569. Numerator: 2046; Denominator: 18569.

Numerator: 3185; Denominator: 18569. Numerator: 2149; Denominator: 18569.

<narrative>Percentage of transgender people that have received an HIV test during the reporting period and know their results</narrative> Module: Comprehensive prevention programs for TGs. <narrative>Percentage of transgender people that have received an HIV test during the reporting period and know their results</narrative> Aggregation: Cumulative annually. Numerator: 62; Denominator: 18569.

Numerator: 995; Denominator: 18569. Numerator: 937; Denominator: 18569.

Numerator: 1532; Denominator: 18569. Numerator: 1910; Denominator: 18569.

Numerator: 2357; Denominator: 18569. Numerator: 2043; Denominator: 18569.

<narrative>Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative> Module: Comprehensive prevention programs for sex workers and their clients. <narrative>Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative> Aggregation: Cumulative annually. Numerator: 53; Denominator: 3904.

Numerator: 283; Denominator: 3904. Numerator: 781; Denominator: 3904.

Numerator: 435; Denominator: 3904. Numerator: 1369; Denominator: 3904.

Numerator: 670; Denominator: 3904. Numerator: 1167; Denominator: 3904.

<narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Module: Comprehensive prevention programs for sex workers and their clients. <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Aggregation: Cumulative annually. Numerator: 56; Denominator: 3904.

Numerator: 269; Denominator: 3904. Numerator: 767; Denominator: 3904.

Numerator: 413; Denominator: 3904. Numerator: 1364; Denominator: 3904.

Numerator: 637; Denominator: 3904. Numerator: 1167; Denominator: 3904.

<narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Aggregation: Cumulative annually. Numerator: 1.

Numerator: 2. Numerator: 9; Denominator: 9; Percentage: 100%.

Numerator: 10. Numerator: 5.

Numerator: 11. Numerator: 7.

Numerator: 788; Denominator: 914.

Numerator: 899; Denominator: 988.

Numerator: 715; Denominator: 808.

<narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative> Module: Treatment, care and support. <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative> Aggregation: Non cumulative - other. Numerator: 53; Denominator: 61.

Numerator: 58; Denominator: 73. Numerator: 53; Denominator: 73.

Numerator: 62; Denominator: 70. Numerator: 56; Denominator: 70.

Numerator: 71; Denominator: 79. Numerator: 61; Denominator: 79.

47045-QUA-C-UNDP-3

The Global Fund to Fight AIDS, Tuberculosis and Malaria

<narrative>Multi-country Western Pacific (MWP) Integrated HIV/TB Program - Oceania - Multicountry Western Pacific (01-Jan-2021-31-Dec-2023)</narrative> Multicountry Western Pacific, TB/HIV, United Nations Development Programme Goals: To halt the spread of HIV among the population of the Western Pacific and maintain HIV incidence rates below 0.1 percent annually; To reduce AIDS-related mortality by strengthening HIV case finding and case management; To reduce the incidence and mortality from all forms of TB in the 11 Pacific Island Countries, thereby contributing to the post-2015 global TB strategy; To promote universal and equitable access to quality diagnosis and appropriate treatment of TB, MDR-TB, TB/DM and TB/HIV patients across 11 Pacific Island Countries. Objectives: Strengthening comprehensiveness and quality of HIV prevention, treatment and care service-delivery models with a view to programmatic sustainability; Strengthen resilience of community and health systems; To provide early rapid and quality diagnosis of TB, MDR-TB, TB/Diabetes and co-morbidities and TB/HIV with specific focus on screening and diagnosis in selected and prioritized hard to reach, vulnerable groups across 11 Pacific Island Countries; To sustain high quality treatment for all forms of TB including drug‐resistant TB and HIV related TB with patient support.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division

Sandra Irbe

Fund Portfolio Manager

+41 58 791 1700 sandra.irbe@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

Multicountry Western Pacific

HIV -> Differentiated HIV Testing Services -> Community-based testing

HIV -> Differentiated HIV Testing Services -> Facility-based testing

HIV -> PMTCT -> Prong 3: Preventing vertical HIV transmission

HIV -> Prevention -> Behavior change interventions

HIV -> Prevention -> Community empowerment

HIV -> Prevention -> Comprehensive sexuality education for AGYW and adolescent boys and young men (ABYM)

HIV -> Prevention -> Condom and lubricant programming

HIV -> Prevention -> Interventions for young key populations

HIV -> Prevention -> Pre-exposure prophylaxis

HIV -> Prevention -> Sexual and reproductive health services, including STIs

HIV -> Reducing human rights-related barriers to HIV/TB services -> HIV and HIV/TB-related legal services

HIV -> Reducing human rights-related barriers to HIV/TB services -> Stigma and discrimination reduction (HIV/TB)

HIV -> Treatment, care and support -> Counseling and psycho-social support

HIV -> Treatment, care and support -> Differentiated ART service delivery and HIV care

HIV -> Treatment, care and support -> Prevention and management of co-infections and co-morbidities (Treatment, care and support)

HIV -> Treatment, care and support -> Treatment monitoring - Viral load

Multicomponent -> Program management -> Coordination and management of national disease control programs

Multicomponent -> Program management -> Grant management

RSSH -> RSSH: Community systems strengthening -> Institutional capacity building, planning and leadership development

RSSH -> RSSH: Community systems strengthening -> Social mobilization, building community linkages and coordination

RSSH -> RSSH: Financial management systems -> Routine grant financial management

RSSH -> RSSH: Health management information systems and M&E -> Analysis, evaluations, reviews and transparency

RSSH -> RSSH: Health management information systems and M&E -> Program and data quality

RSSH -> RSSH: Health management information systems and M&E -> Routine reporting

RSSH -> RSSH: Health products management systems -> Procurement capacity

RSSH -> RSSH: Health products management systems -> Storage and distribution capacity

RSSH -> RSSH: Health sector governance and planning -> Policy and planning for national disease control programs

RSSH -> RSSH: Human resources for health, including community health workers -> Community health workers: Education and production

RSSH -> RSSH: Human resources for health, including community health workers -> Community health workers: In-service training

RSSH -> RSSH: Human resources for health, including community health workers -> Community health workers: Remuneration and deployment

RSSH -> RSSH: Human resources for health, including community health workers -> Education and production of new health workers (excluding community health workers)

RSSH -> RSSH: Human resources for health, including community health workers -> In-service training (excluding community health workers)

RSSH -> RSSH: Human resources for health, including community health workers -> Remuneration & deployment of existing/new staff (excluding community health workers)

RSSH -> RSSH: Integrated service delivery and quality improvement -> Quality of care

RSSH -> RSSH: Integrated service delivery and quality improvement -> Service delivery infrastructure

RSSH -> RSSH: Laboratory systems -> Quality management systems and accreditation

Tuberculosis -> MDR-TB -> Case detection and diagnosis (MDR-TB)

Tuberculosis -> MDR-TB -> Community MDR-TB care delivery

Tuberculosis -> MDR-TB -> Treatment (MDR-TB)

Tuberculosis -> TB care and prevention -> Case detection and diagnosis (TB care and prevention)

Tuberculosis -> TB care and prevention -> Collaborative activities with other programs and sectors (TB care and prevention)

Tuberculosis -> TB care and prevention -> Community TB care delivery

Tuberculosis -> TB care and prevention -> Engaging all care providers (TB care and prevention)

Tuberculosis -> TB care and prevention -> Prevention (TB care and prevention)

Tuberculosis -> TB care and prevention -> Treatment (TB care and prevention)

Tuberculosis -> TB/HIV -> Collaborative activities with other programs and sectors (TB/HIV)

Tuberculosis -> TB/HIV -> Community TB/HIV care delivery

Tuberculosis -> TB/HIV -> Engaging all care providers (TB/HIV)

Tuberculosis -> TB/HIV -> TB/HIV - Collaborative interventions

Tuberculosis -> TB/HIV -> TB/HIV - Prevention

Tuberculosis -> TB/HIV -> TB/HIV - Screening, testing and diagnosis

Tuberculosis -> TB/HIV -> Treatment (TB/HIV)

2415228.02

5014927.00

5325391.60

844638.88

5510952.44 Global Fund commitment to QUA-C-UNDPP03.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1070435.57 Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

838350.54 Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1134035.10 Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund commitment to QUA-C-UNDPP03.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

4478266.23 Global Fund commitment to QUA-C-UNDPP03.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-2468131.23 Global Fund commitment to QUA-C-UNDPP03.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

68470.50 Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1012740.00 Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

100645.50 Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

702378.00 Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1300328.00 Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

50000.00 Global Fund commitment to QUA-C-UNDPP03.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-25000.00 Global Fund commitment to QUA-C-UNDPP03.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund disbursement to QUA-C-UNDPP03 (Other 3rd Party).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-1293704.23 Global Fund commitment to QUA-C-UNDPP03.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1364950.00 Global Fund commitment to QUA-C-UNDPP03.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

722211.00 Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

642739.00 Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

4315891.88 Global Fund commitment to QUA-C-UNDPP03.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1107709.64 Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

209555.00 Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1187770.92 Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

849644.00 Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund disbursement to QUA-C-UNDPP03 (Other 3rd Party).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

95322.00 Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

865890.32 Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1355256.70 Global Fund commitment to QUA-C-UNDPP03.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

113549.75 Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund commitment to QUA-C-UNDPP03.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-1241706.95 Global Fund commitment to QUA-C-UNDPP03.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1216706.95 Global Fund commitment to QUA-C-UNDPP03.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-25000.00 Global Fund commitment to QUA-C-UNDPP03.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

796388.94 Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

420318.01 Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund commitment to QUA-C-UNDPP03.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund disbursement to QUA-C-UNDPP03 (Other 3rd Party).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-13230.08 Global Fund commitment to QUA-C-UNDPP03.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

13230.08 Funds returned to the Global Fund from QUA-C-UNDPP03 (Other 3rd Party).

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

373312.00 Funds returned to the Global Fund from QUA-C-UNDPP03 (Multilateral).

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

-373312.00 Global Fund commitment to QUA-C-UNDPP03.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-16874.00 Global Fund commitment to QUA-C-UNDPP03.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

16874.00 Funds returned to the Global Fund from QUA-C-UNDPP03 (Other 3rd Party).

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

2415228.46 Expenditure reported by United Nations Development Programme for QUA-C-UNDPP03, Jan 2021 to Dec 2021.

United Nations Development Programme

4028218.79 Expenditure reported by United Nations Development Programme for QUA-C-UNDPP03, Jan 2022 to Dec 2022.

United Nations Development Programme

5310853.47 Expenditure reported by United Nations Development Programme for QUA-C-UNDPP03, Jan 2023 to Dec 2023.

United Nations Development Programme

905221.51 Expenditure reported by United Nations Development Programme for QUA-C-UNDPP03, Jan 2024 to Jun 2024.

United Nations Development Programme

262458.65 Expenditure reported by United Nations Development Programme for QUA-C-UNDPP03, Jul 2024 to Dec 2024.

United Nations Development Programme

162612.51 Expenditure reported by United Nations Development Programme for QUA-C-UNDPP03, Jan 2025 to Jun 2025.

United Nations Development Programme

<narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime.

<narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants.

<narrative>2020 - Funding Request - Window 3 - TB/HIV - Oceania - English</narrative> Funding Request of funding request FR870-MCWP-C.

<narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 1160; Denominator: 9284; Percentage: 12.49%. Numerator: 0. Numerator: 0. Numerator: 1160. Numerator: 0.

Numerator: 1197; Denominator: 9284; Percentage: 12.89%. Numerator: 1039; Denominator: 9284; Percentage: 11.2%.

Numerator: 1234; Denominator: 9284; Percentage: 13.29%. Numerator: 1511; Denominator: 9284; Percentage: 16.3%. Numerator: 824; Denominator: 1511; Percentage: 54.53%. Numerator: 687; Denominator: 1511; Percentage: 45.47%. Numerator: 1; Denominator: 1511; Percentage: 0.07%. Numerator: 1510; Denominator: 1511; Percentage: 99.93%.

Numerator: 1274; Denominator: 9284; Percentage: 13.72%. Numerator: 1545; Denominator: 9284; Percentage: 16.6%.

<narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 1364; Denominator: 3904; Percentage: 34.94%. Numerator: 1. Numerator: 1. Numerator: 0. Numerator: 0. Numerator: 1. Numerator: 1. Numerator: 1. Numerator: 1.

Numerator: 1364; Denominator: 3904; Percentage: 34.94%. Numerator: 1668; Denominator: 3904; Percentage: 42.7%.

Numerator: 1424; Denominator: 3904; Percentage: 36.48%. Numerator: 1553; Denominator: 3904; Percentage: 39.8%. Numerator: 806; Denominator: 1553; Percentage: 51.9%. Numerator: 747; Denominator: 1553; Percentage: 48.1%. Numerator: 1553; Denominator: 1553; Percentage: 100%.

Numerator: 1490; Denominator: 3904; Percentage: 38.17%. Numerator: 1590; Denominator: 3904; Percentage: 40.7%. Numerator: 818; Denominator: 1590; Percentage: 51.45%. Numerator: 772; Denominator: 1590; Percentage: 48.55%. Numerator: 1590; Denominator: 1590; Percentage: 100%. Numerator: 0; Denominator: 1590; Percentage: 0%.

<narrative>Percentage of transgender people that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of transgender people that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 1910; Denominator: 18569; Percentage: 10.29%. Numerator: 0. Numerator: 0. Numerator: 0. Numerator: 0. Numerator: 1910. Numerator: 1910. Numerator: 0. Numerator: 0.

Numerator: 1954; Denominator: 18569; Percentage: 10.52%. Numerator: 2270; Denominator: 18569; Percentage: 12.2%.

Numerator: 2008; Denominator: 18569; Percentage: 10.81%. Numerator: 2279; Denominator: 18569; Percentage: 12.3%. Numerator: 1476; Denominator: 2279; Percentage: 64.77%. Numerator: 803; Denominator: 2279; Percentage: 35.23%. Numerator: 1; Denominator: 2279; Percentage: 0.04%. Numerator: 2278; Denominator: 2279; Percentage: 99.96%.

Numerator: 2066; Denominator: 18569; Percentage: 11.13%. Numerator: 2326; Denominator: 18569; Percentage: 12.5%. Numerator: 1782; Denominator: 2326; Percentage: 76.61%. Numerator: 544; Denominator: 2326; Percentage: 23.39%. Numerator: 2326; Denominator: 2326; Percentage: 100%. Numerator: 0; Denominator: 2326; Percentage: 0%.

<narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Module: MDR-TB. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.

<narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Module: Prevention. <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 1472; Denominator: 9284; Percentage: 15.86%. Numerator: 689. Numerator: 689. Numerator: 783. Numerator: 783.

Numerator: 1515; Denominator: 9284; Percentage: 16.32%. Numerator: 1600; Denominator: 9284; Percentage: 17.2%.

Numerator: 1562; Denominator: 9284; Percentage: 16.82%. Numerator: 1568; Denominator: 9284; Percentage: 16.9%. Numerator: 719; Denominator: 1568; Percentage: 45.85%. Numerator: 849; Denominator: 1568; Percentage: 54.15%.

Numerator: 1612; Denominator: 9284; Percentage: 17.36%. Numerator: 1724; Denominator: 9284; Percentage: 18.6%. Numerator: 1113; Denominator: 1724; Percentage: 64.56%. Numerator: 611; Denominator: 1724; Percentage: 35.44%.

<narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Module: Prevention. <narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 1369; Denominator: 3904; Percentage: 35.07%. Numerator: 665. Numerator: 665. Numerator: 704. Numerator: 704. Numerator: 1369. Numerator: 1369.

Numerator: 1435; Denominator: 3904; Percentage: 36.76%. Numerator: 1833; Denominator: 3904; Percentage: 47%.

Numerator: 1499; Denominator: 3904; Percentage: 38.4%. Numerator: 1585; Denominator: 3904; Percentage: 40.6%. Numerator: 765; Denominator: 1585; Percentage: 48.26%. Numerator: 820; Denominator: 1585; Percentage: 51.74%. Numerator: 1585; Denominator: 1585; Percentage: 100%.

Numerator: 1568; Denominator: 3904; Percentage: 40.16%. Numerator: 1590; Denominator: 3904; Percentage: 40.7%. Numerator: 818; Denominator: 1590; Percentage: 51.45%. Numerator: 772; Denominator: 1590; Percentage: 48.55%. Numerator: 1590; Denominator: 1590; Percentage: 100%.

<narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative> Module: Prevention. <narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 2046; Denominator: 18569; Percentage: 11.02%. Numerator: 736. Numerator: 736. Numerator: 1309. Numerator: 1309.

Numerator: 2101; Denominator: 18569; Percentage: 11.31%. Numerator: 2297; Denominator: 18569; Percentage: 12.4%.

Numerator: 2159; Denominator: 18569; Percentage: 11.63%. Numerator: 2394; Denominator: 18569; Percentage: 12.9%. Numerator: 856; Denominator: 2394; Percentage: 35.76%. Numerator: 1538; Denominator: 2394; Percentage: 64.24%.

Numerator: 2221; Denominator: 18569; Percentage: 11.96%. Numerator: 2541; Denominator: 18569; Percentage: 13.7%. Numerator: 1897; Denominator: 2541; Percentage: 74.66%. Numerator: 644; Denominator: 2541; Percentage: 25.34%.

<narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative> Module: TB care and prevention. <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 89. Numerator: 0. Numerator: 5.

Numerator: 90. Numerator: 185.

Numerator: 115. Numerator: 357.

Numerator: 145. Numerator: 460. Numerator: 4; Denominator: 460; Percentage: 0.87%. Numerator: 0; Denominator: 460; Percentage: 0%.

<narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 895. Numerator: 198. Numerator: 198. Numerator: 602. Numerator: 602. Numerator: 335. Numerator: 335. Numerator: 381. Numerator: 381. Numerator: 421. Numerator: 421. Numerator: 459. Numerator: 459. Numerator: 342. Numerator: 342. Numerator: 1. Numerator: 1.

Numerator: 907. Numerator: 653.

Numerator: 927. Numerator: 649. Numerator: 100; Denominator: 649; Percentage: 15.41%. Numerator: 549; Denominator: 649; Percentage: 84.59%. Numerator: 361; Denominator: 649; Percentage: 55.62%. Numerator: 162; Denominator: 649; Percentage: 24.96%. Numerator: 333; Denominator: 649; Percentage: 51.31%. Numerator: 288; Denominator: 649; Percentage: 44.38%. Numerator: 487; Denominator: 649; Percentage: 75.04%.

Numerator: 948. Numerator: 1156. Numerator: 820; Denominator: 1156; Percentage: 70.93%. Numerator: 336; Denominator: 1156; Percentage: 29.07%. Numerator: 510; Denominator: 1156; Percentage: 44.12%. Numerator: 550; Denominator: 1156; Percentage: 47.58%. Numerator: 606; Denominator: 1156; Percentage: 52.42%. Numerator: 656; Denominator: 1156; Percentage: 56.75%. Numerator: 498; Denominator: 1156; Percentage: 43.08%. Numerator: 2; Denominator: 1156; Percentage: 0.17%.

<narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Module: TB care and prevention. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 899; Denominator: 988. Numerator: 617; Denominator: 899. Numerator: 617; Denominator: 899. Numerator: 197; Denominator: 899. Numerator: 197; Denominator: 899. Numerator: 428; Denominator: 899. Numerator: 428; Denominator: 899. Numerator: 386; Denominator: 899. Numerator: 386; Denominator: 899. Numerator: 262; Denominator: 899. Numerator: 262; Denominator: 899. Numerator: 552; Denominator: 899. Numerator: 552; Denominator: 899. Numerator: 0; Denominator: 899. Numerator: 0; Denominator: 899.

Numerator: 644; Denominator: 774.

Numerator: 566; Denominator: 655. Numerator: 85; Denominator: 566. Numerator: 481; Denominator: 566. Numerator: 436; Denominator: 566. Numerator: 129; Denominator: 566. Numerator: 273; Denominator: 566. Numerator: 289; Denominator: 566. Numerator: 1; Denominator: 566.

Numerator: 562; Denominator: 661. Numerator: 467; Denominator: 562. Numerator: 95; Denominator: 562. Numerator: 245; Denominator: 562. Numerator: 317; Denominator: 562. Numerator: 425; Denominator: 562. Numerator: 137; Denominator: 562. Numerator: 0; Denominator: 562.

<narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Module: Treatment, care and support. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 56; Denominator: 70.

Numerator: 68; Denominator: 80. Numerator: 64; Denominator: 66.

Numerator: 75; Denominator: 85. Numerator: 66; Denominator: 69.

Numerator: 81; Denominator: 90. Numerator: 64; Denominator: 68.

47045-QUA-C-UNDP-4

The Global Fund to Fight AIDS, Tuberculosis and Malaria

<narrative>Multi-country Western Pacific Integrated HIV/TB Program - Oceania - Multicountry Western Pacific (01-Jan-2024-31-Dec-2026)</narrative> Multicountry Western Pacific, TB/HIV, United Nations Development Programme Goal: To support 12 Pacific Island countries in ending AIDS and tuberculosis in the post-Covid period. Objectives: To strengthen comprehensiveness and quality of HIV prevention, treatment and care service-delivery models with a view to programmatic sustainability; To provide early rapid and quality diagnosis of TB, DR-TB and comorbidities with specific focus on hard to reach, vulnerable groups across 12 Pacific Island countries; To sustain high quality treatment for all forms of TB including drug-resistant TB and HIV-related TB with patient support; To build up the resilience of healthcare systems, including community systems, to deliver integrated people-centered models of HIV and TB care.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division

Sandra Irbe

Fund Portfolio Manager

+41 58 791 1700 sandra.irbe@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

Multicountry Western Pacific

HIV -> Differentiated HIV Testing Services -> Community-based testing for AGYW and their male sexual partners programs

HIV -> Differentiated HIV Testing Services -> Community-based testing for KP programs

HIV -> Differentiated HIV Testing Services -> Community-based testing outside of KP and AGYW programs

HIV -> Differentiated HIV Testing Services -> Facility-based testing for adolescent girls and young women (AGYW) and their male sexual partners programs

HIV -> Differentiated HIV Testing Services -> Facility-based testing for key population (KP) programs

HIV -> Differentiated HIV Testing Services -> Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs

HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Integrated testing of pregnant women for HIV, syphilis and hepatitis B

HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Post-natal infant prophylaxis

HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Prevention of incident HIV among pregnant and breastfeeding women

HIV -> Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -> Comprehensive sexuality education for adolescent girls and young women (AGYW) and adolescent boys and young men (ABYM)

HIV -> Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -> HIV prevention communication, information and demand creation for AGYW in high HIV incidence settings

HIV -> Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -> Pre-exposure prophylaxis (PrEP) programming for male sexual partners of AGYW in high HIV incidence settings

HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Condom and lubricant programming for MSM

HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> HIV prevention communication, information and demand creation for MSM

HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Pre-exposure prophylaxis (PrEP) programming for MSM

HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM

HIV -> Prevention package for other vulnerable populations (OVP) -> Condom and lubricant programming for OVP

HIV -> Prevention package for other vulnerable populations (OVP) -> HIV prevention communication, information and demand creation for OVP

HIV -> Prevention package for other vulnerable populations (OVP) -> Removing human rights-related barriers to prevention for OVP

HIV -> Prevention package for other vulnerable populations (OVP) -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for OVP

HIV -> Prevention package for sex workers, their clients and other sexual partners -> HIV prevention communication, information and demand creation for sex workers

HIV -> Prevention package for sex workers, their clients and other sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers

HIV -> Prevention package for transgender people and their sexual partners -> Community empowerment for transgender people

HIV -> Prevention package for transgender people and their sexual partners -> Condom and lubricant programming for transgender people

HIV -> Prevention package for transgender people and their sexual partners -> HIV prevention communication, information and demand creation for transgender people

HIV -> Prevention package for transgender people and their sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for transgender people

HIV -> Reducing human rights-related barriers to HIV/TB services -> Community mobilization and advocacy for human rights

HIV -> Reducing human rights-related barriers to HIV/TB services -> Eliminating stigma and discrimination in all settings

HIV -> Reducing human rights-related barriers to HIV/TB services -> Ensuring nondiscriminatory provision of health care

HIV -> Reducing human rights-related barriers to HIV/TB services -> Improving laws, regulations and policies relating to HIV and HIV/TB

HIV -> Reducing human rights-related barriers to HIV/TB services -> Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity

HIV -> Treatment, care and support -> Diagnosis and management of advanced HIV disease (adults and children)

HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - adults (15 and above)

HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - children (under 15)

HIV -> Treatment, care and support -> Treatment monitoring - Viral load and antiretroviral (ARV) toxicity

Multicomponent -> Program management -> Coordination and management of national disease control programs

Multicomponent -> Program management -> Grant management

RSSH -> RSSH/PP: Human resources for health (HRH) and quality of care -> RSSH/PP: Community health workers: In-service training

RSSH -> RSSH/PP: Human resources for health (HRH) and quality of care -> RSSH/PP: Community health workers: contracting, remuneration and retention

RSSH -> RSSH/PP: Human resources for health (HRH) and quality of care -> RSSH/PP: In-service training (excluding community health workers)

RSSH -> RSSH/PP: Human resources for health (HRH) and quality of care -> RSSH/PP: Quality improvement and capacity building for quality of care

RSSH -> RSSH/PP: Human resources for health (HRH) and quality of care -> RSSH/PP: Remuneration and deployment of existing/new staff (excluding community health workers)

RSSH -> RSSH: Community systems strengthening -> Capacity building and leadership development

RSSH -> RSSH: Community systems strengthening -> Community engagement, linkages and coordination

RSSH -> RSSH: Community systems strengthening -> Community-led research and advocacy

RSSH -> RSSH: Monitoring and evaluation systems -> Analyses, evaluations, reviews and data use

RSSH -> RSSH: Monitoring and evaluation systems -> Routine reporting

RSSH -> RSSH: Monitoring and evaluation systems -> Surveillance for HIV, tuberculosis and malaria

RSSH -> RSSH: Monitoring and evaluation systems -> Surveys

Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB diagnosis/drug susceptibility testing (DST)

Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB treatment, care and support

Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Children and adolescents

Tuberculosis -> TB diagnosis, treatment and care -> TB screening and diagnosis

Tuberculosis -> TB diagnosis, treatment and care -> TB treatment, care and support

Tuberculosis -> TB/DR-TB Prevention -> Infection prevention and control (IPC)

Tuberculosis -> TB/DR-TB Prevention -> Preventive treatment

Tuberculosis -> TB/DR-TB Prevention -> Screening/testing for TB infection

Tuberculosis -> TB/HIV -> TB/HIV - Screening, testing and diagnosis

3238691.67

3793556.74

3415944.44

5813933.48 Global Fund commitment to QUA-C-UNDPP04.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

3738592.60 Global Fund disbursement to QUA-C-UNDPP04 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

2069526.88 Global Fund disbursement to QUA-C-UNDPP04 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

16874.00 Global Fund commitment to QUA-C-UNDPP04.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

16874.00 Global Fund disbursement to QUA-C-UNDPP04 (Other 3rd Party).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

2353739.85 Global Fund commitment to QUA-C-UNDPP04.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-5814.00 Global Fund commitment to QUA-C-UNDPP04.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

784579.95 Global Fund disbursement to QUA-C-UNDPP04 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

737340.74 Global Fund disbursement to QUA-C-UNDPP04 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

831819.16 Global Fund disbursement to QUA-C-UNDPP04 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

2070787.20 Global Fund commitment to QUA-C-UNDPP04.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

704410.20 Global Fund disbursement to QUA-C-UNDPP04 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1366377.00 Global Fund disbursement to QUA-C-UNDPP04 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

3235413.17 Expenditure reported by United Nations Development Programme for QUA-C-UNDPP04, Jan 2024 to Dec 2024.

United Nations Development Programme

3158259.63 Expenditure reported by United Nations Development Programme for QUA-C-UNDPP04, Jan 2025 to Dec 2025.

United Nations Development Programme

<narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime.

<narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants.

<narrative>2023 - Funding Request - Window 2 - TB/HIV - Oceania - English</narrative> Funding Request of funding request FR1475-MCWP-C.

<narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Geographic coverage: National, 100% of national program target. Numerator: 1511; Denominator: 9284.

Numerator: 1914; Denominator: 10770. Numerator: 1871; Denominator: 10770.

Numerator: 2374; Denominator: 10770. Numerator: 2095; Denominator: 10770.

Numerator: 2440; Denominator: 10770.

<narrative>Percentage of TG that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of TG that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Geographic coverage: National, 100% of national program target. Numerator: 2279; Denominator: 18569.

Numerator: 2400; Denominator: 12016. Numerator: 1895; Denominator: 12016.

Numerator: 2930; Denominator: 12016. Numerator: 2101; Denominator: 12016.

Numerator: 3048; Denominator: 12016.

<narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Geographic coverage: National, 100% of national program target. Numerator: 1553; Denominator: 3904.

Numerator: 1685; Denominator: 4764. Numerator: 1646; Denominator: 4764.

Numerator: 1895; Denominator: 4764. Numerator: 1620; Denominator: 4764.

Numerator: 2115; Denominator: 4764.

<narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Module: Prevention package for men who have sex with men (MSM) and their sexual partners. <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Numerator: 1568; Denominator: 9284.

Numerator: 2015; Denominator: 10770. Numerator: 1778; Denominator: 10770.

Numerator: 2499; Denominator: 10770. Numerator: 2263; Denominator: 10770.

Numerator: 2568; Denominator: 10770.

<narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Module: Prevention package for sex workers, their clients and other sexual partners. <narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Numerator: 1585; Denominator: 3904.

Numerator: 1774; Denominator: 4764. Numerator: 1646; Denominator: 4764.

Numerator: 1995; Denominator: 4764. Numerator: 1733; Denominator: 4764.

Numerator: 2226; Denominator: 4764.

<narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative> Module: Prevention package for transgender people and their sexual partners. <narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative> Geographic coverage: National, 100% of national program target. Numerator: 2394; Denominator: 18569.

Numerator: 2526; Denominator: 12016. Numerator: 2062; Denominator: 12016.

Numerator: 3084; Denominator: 12016. Numerator: 2358; Denominator: 12016.

Numerator: 3208; Denominator: 12016.

<narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Geographic coverage: National, 100% of national program target.

<narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative> Module: TB diagnosis, treatment and care. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative> Geographic coverage: National, 100% of national program target. Numerator: 547; Denominator: 1047.

Numerator: 911; Denominator: 1138. Numerator: 1313; Denominator: 1534.

Numerator: 1029; Denominator: 1210. Numerator: 1027; Denominator: 1583.

Numerator: 1155; Denominator: 1283.

<narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative> Geographic coverage: National, 100% of national program target.

Numerator: 1253; Denominator: 1557.

Numerator: 1174; Denominator: 1536.

<narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Module: TB/DR-TB Prevention. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Geographic coverage: National, 100% of national program target.

Numerator: 891; Denominator: 2621. Numerator: 1372; Denominator: 6176.

Numerator: 1074; Denominator: 2903. Numerator: 1863; Denominator: 5962.

Numerator: 1278; Denominator: 3196.